Identificación de metabolitos asociados con la diabetes mellitus tipo 1, 2 y gestacional: Una revisión de la literatura.

Vista sencilla de ítem
dc.contributor.advisorBuritica Herrera, Hector Mario
dc.contributor.authorRueda Arcila, Ana María
dc.contributor.authorTorres Ortiz, Alejandro
dc.coverage.spatialPereiraspa
dc.creator.emailanam-ruedaa@unilibre.edu.cospa
dc.creator.emailalejandro-torreso@unilibre.edu.cospa
dc.date.accessioned2024-06-11T13:50:44Z
dc.date.available2024-06-11T13:50:44Z
dc.date.created2024-05-31
dc.description.abstractLa diabetes es una conocida enfermedad crónica que afecta a millones de personas alrededor del mundo, esta se caracteriza por la presencia de hiperglucemia. El objetivo de este artículo fue determinar los metabolitos asociados, con la aparición y tratamiento de la diabetes mellitus tipo 1, 2 y gestacional. La información de este estudio se obtuvo de las bases de datos, PubMed, ScienceDirect, Scopus y otras fuentes de búsqueda, como bases de datos de universidades. Los artículos seleccionados se utilizaron para ver la relación que tenían algunos metabolitos del metabolismo de las proteínas, lípidos y carbohidratos con la diabetes mellitus. En total se seleccionaron 30 artículos, que brindaron información sobre la asociación de metabolitos como los BCAA, aminoácidos aromáticos, acilcarnitinas, hexosas, entre otros, con la diabetes tipo 1, 2 y gestacional. Esta revisión sugiere que la combinación de biomarcadores metabólicos, como aminoácidos, azúcares y ácidos grasos, puede proporcionar una visión integral del riesgo, diagnóstico y progresión de la diabetes mellitus.spa
dc.description.abstractenglishDiabetes is a well-known chronic disease that affects millions of people around the world; it is characterized by the presence of hyperglycemia. The objective of this article was to determine the metabolites associated with the onset and treatment of type 1, 2 and gestational diabetes mellitus. The information for this study was obtained from databases, PubMed, ScienceDirect, Scopus and other search sources, such as university databases. The selected articles were used to see the relationship that some metabolites of protein, lipid and carbohydrate metabolism had with diabetes mellitus. In total, 30 articles were selected, which provided information on the association of metabolites such as BCAAs, aromatic amino acids, acylcarnitines, hexoses, among others, with type 1, 2 and gestational diabetes. This review suggests that the combination of metabolic biomarkers, such as amino acids, sugars and fatty acids, can provide a comprehensive view of the risk, diagnosis and progression of diabetes mellitus.spa
dc.description.sponsorshipUniversidad Libre Seccional Pereira -- Facultad de Ciencias de la Salud, Exactas y Naturales -- Nutrición y Dietéticaspa
dc.formatPDFspa
dc.identifier.urihttps://hdl.handle.net/10901/29262
dc.relation.referencesIDF Diabetes Atlas 10th edition [Internet]. Available from: www.diabetesatlas.orgspa
dc.relation.referencesCho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018 Apr 1;138:271–81.spa
dc.relation.references4 metabolómica aplicaciones clave en salud y producción de alimentos.spa
dc.relation.referencesJin Q, Ma RCW. Metabolomics in diabetes and diabetic complications: Insights from epidemiological studies. Vol. 10, Cells. MDPI; 2021.spa
dc.relation.referencesRinschen MM, Ivanisevic J, Giera M, Siuzdak G. Identification of bioactive metabolites using activity metabolomics. Vol. 20, Nature Reviews Molecular Cell Biology. Nature Publishing Group; 2019. p. 353–67.spa
dc.relation.referencesZhang M, Yang H. Perspectives from metabolomics in the early diagnosis and prognosis of gestational diabetes mellitus. Vol. 13, Frontiers in Endocrinology. Frontiers Media S.A.; 2022.spa
dc.relation.referencesKortesniemi M, Noerman S, Kårlund A, Raita J, Meuronen T, Koistinen V, et al. Nutritional metabolomics: Recent developments and future needs. Vol. 77, Current Opinion in Chemical Biology. Elsevier Ltd; 2023.spa
dc.relation.referencesDunn WB, Ellis DI. Metabolomics: Current analytical platforms and methodologies. TrAC - Trends in Analytical Chemistry. 2005;24(4):285–94.spa
dc.relation.referencesWishart DS. Metabolomics for Investigating Physiological and Pathophysiological Processes. Physiol Rev [Internet]. 2019;99:1819–75. Available from: www.prv.orgspa
dc.relation.referencesUrrútia G, Bonfill1 X. EDITORIAL LA DECLARACIÓN PRISMA: UN PASO ADELANTE EN LA MEJORA DE LAS PUBLICACIONES DE LA REVISTA ESPAÑOLA DE SALUD PÚBLICA [Internet]. Available from: http://www.prismaspa
dc.relation.references2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2021. Diabetes Care. 2021 Jan 1;44:S15–33.spa
dc.relation.referencesArneth B, Arneth R, Shams M. Metabolomics of type 1 and type 2 diabetes. Vol. 20, International Journal of Molecular Sciences. MDPI AG; 2019.spa
dc.relation.referencesChen ZZ, Gerszten RE. Metabolomics and Proteomics in Type 2 Diabetes. Vol. 126, Circulation Research. Lippincott Williams and Wilkins; 2020. p. 1613–27.spa
dc.relation.referencesMorze J, Wittenbecher C, Schwingshackl L, Danielewicz A, Rynkiewicz A, Hu FB, et al. Metabolomics and Type 2 Diabetes Risk: An Updated Systematic Review and Meta-analysis of Prospective Cohort Studies. Diabetes Care. 2022 Apr 1;45(4):1013–24.spa
dc.relation.referencesWittenbecher C, Guasch-Ferr M, Haslam DE, Dennis C, Li J, Bhupathiraju SN, et al. Changes in metabolomics profiles over ten years and subsequent risk of developing type 2 diabetes: Results from the Nurses’ Health Study. EBioMedicine [Internet]. 2022;75:103799. Available from: https://doi.org/10.1016/j.spa
dc.relation.referencesLong J, Yang Z, Wang L, Han Y, Peng C, Yan C, et al. Metabolite biomarkers of type 2 diabetes mellitus and pre-diabetes: a systematic review and meta-analysis. BMC Endocr Disord. 2020 Dec 1;20(1).spa
dc.relation.referencesJung Y, Ahn E, Park T, Hwang GS. Longitudinal study investigating serum metabolites and their association with type 2 diabetes risk in a Korean population. Diabetes Obes Metab. 2023 Aug 1;25(8):2120–30.spa
dc.relation.referencesKaragiannidis E, Moysidis D V., Papazoglou AS, Panteris E, Deda O, Stalikas N, et al. Prognostic significance of metabolomic biomarkers in patients with diabetes mellitus and coronary artery disease. Cardiovasc Diabetol. 2022 Dec 1;21(1).spa
dc.relation.referencesDomínguez-López I, Lozano-Castellón J, Vallverdú-Queralt A, Jáuregui O, Martínez-González MÁ, Hu FB, et al. Urinary metabolomics of phenolic compounds reveals biomarkers of type-2 diabetes within the PREDIMED trial. Biomedicine and Pharmacotherapy. 2023 Jun 1;162.spa
dc.relation.referencesTeruya T, Sunagawa S, Mori A, Masuzaki H, Yanagida M. Markers for obese and non-obese Type 2 diabetes identified using whole blood metabolomics. Sci Rep. 2023 Dec 1;13(1).spa
dc.relation.referencesMao X, Chen X, Chen C, Zhang H, Law KP. Metabolomics in gestational diabetes. Vol. 475, Clinica Chimica Acta. Elsevier B.V.; 2017. p. 116–27.spa
dc.relation.referencesRazo-Azamar M, Nambo-Venegas R, Meraz-Cruz N, Guevara-Cruz M, Ibarra-González I, Vela-Amieva M, et al. An early prediction model for gestational diabetes mellitus based on metabolomic biomarkers. Diabetol Metab Syndr. 2023 Dec 1;15(1).spa
dc.relation.referencesHeath H, Rosario R, McMichael LE, Fanter R, Alarcon N, Quintana-Diaz A, et al. Gestational Diabetes Is Characterized by Decreased Medium-Chain Acylcarnitines and Elevated Purine Degradation Metabolites across Pregnancy: A Case-Control Time-Course Analysis. J Proteome Res. 2023 Jun 2;22(6):1603–13.spa
dc.relation.referencesMeek CL, Stewart ZA, Feig DS, Furse S, Neoh SL, Koulman A, et al. Metabolomic insights into maternal and neonatal complications in pregnancies affected by type 1 diabetes. Diabetologia. 2023 Nov 1;spa
dc.relation.referencesHeath H, Degreef K, Rosario R, Smith MK, Mitchell I, Pilolla K, et al. Identification of potential biomarkers and metabolic insights for gestational diabetes prevention: A review of evidence contrasting gestational diabetes versus weight loss studies that may direct future nutritional metabolomics studies. Vol. 107, Nutrition. Elsevier Inc.; 2023.spa
dc.relation.referencesRani Agarwal N, Kachhawa G, Oyeyemi BF, Bhavesh NS. Metabolic profiling of serum and urine in preeclampsia and gestational diabetes in early pregnancy. Med Drug Discov. 2022 Dec 1;16.spa
dc.relation.referencesMokkala K, Vahlberg T, Pellonperä O, Houttu N, Koivuniemi E, Laitinen K. Distinct Metabolic Profile in Early Pregnancy of Overweight and Obese Women Developing Gestational Diabetes. Journal of Nutrition. 2020 Jan 1;150(1):31–7.spa
dc.relation.referencesZhou CD, Seah RL, Papatheodorou SI. The role of biomarker ykl-40 in risk stratification and diagnosis of gestational diabetes mellitus: A systematic review and meta-analysis. Vol. 3, Endocrine and Metabolic Science. Elsevier Ltd; 2021.spa
dc.relation.referencesMcarthur KL, Zhang M, Hong X, Wang G, Buckley JP, Wang X, et al. O R I G I N A L R E S E A R C H Trimethylamine N-Oxide and Its Precursors Are Associated with Gestational Diabetes Mellitus and Pre-Eclampsia in the Boston Birth Cohort [Internet]. Available from: https://academic.oup.com/cdn/.spa
dc.relation.referencesHuhtala MS, Rönnemaa T, Paavilainen E, Niinikoski H, Pellonperä O, Juhila J, et al. Prediction of pre-diabetes and type 2 diabetes nine years postpartum using serum metabolome in pregnant women with gestational diabetes requiring pharmacological treatment. J Diabetes Complications. 2023 Jul 1;37(7).spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa
dc.rights.licenseAtribución-NoComercial-SinDerivadas 2.5 Colombiaspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/spa
dc.subjectMetabolómicaspa
dc.subjectDiabetes Mellitusspa
dc.subjectBCAAspa
dc.subjectÁcidos grasosspa
dc.subjectEnfermedad crónicaspa
dc.subject.subjectenglishMetabolomicsspa
dc.subject.subjectenglishDiabetes Mellitusspa
dc.subject.subjectenglishBCAAspa
dc.subject.subjectenglishFatty acidsspa
dc.subject.subjectenglishChronic diseasespa
dc.titleIdentificación de metabolitos asociados con la diabetes mellitus tipo 1, 2 y gestacional: Una revisión de la literatura.spa
dc.type.driverinfo:eu-repo/semantics/bachelorThesisspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.type.localTesis de Pregradospa

Archivos

Bloque original

Mostrando 1 - 2 de 2
Miniatura
Nombre:
Identificación de metabolitos asociados con la diabetes mellitus tipo 1, 2 y gestacional Una revisión de la literatura.pdf
Tamaño:
438.98 KB
Formato:
Adobe Portable Document Format
Descripción:
Descargar
Miniatura
Nombre:
formato-autorizacion-repositorio.pdf
Tamaño:
444.22 KB
Formato:
Adobe Portable Document Format
Descripción:
Descargar

Bloque de licencias

Mostrando 1 - 1 de 1
Miniatura
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

Nutrición y Dietética